Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses

Immunopharmacology. 1990 Jul-Aug;20(1):57-61. doi: 10.1016/0162-3109(90)90007-2.

Abstract

The macrolide antibiotic FK-506 causes a strong inhibition of human T and B cell proliferation in vitro in concentrations 100-fold lower than cyclosporine (CsA). However, B cell activation appears to be less sensitive to the immunosuppressive action of FK-506 than T cell responses. There was no indication of a synergistic interaction of the two agents. In contrast, CsA added together with FK could counteract the immunosuppressive activity of the latter drug.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • Cells, Cultured
  • Cyclosporins / pharmacology*
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Lymphocyte Activation / drug effects*
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology
  • Tacrolimus

Substances

  • Anti-Bacterial Agents
  • Cyclosporins
  • Immunosuppressive Agents
  • Tacrolimus